Fund HoldingsvenBio Partners LLC

Total Portfolio Value
$123.56M
Total Bought
$0
Total Sold
$14.04M
Net Transaction
-$14.04M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
LYELL IMMUNOPHARMA INC7,102,1907,102,19004,5453,8213.09%-724
HARMONY BIOSCIENCES HLDGS IN(HRMY)539,194489,194-50,00018,55416,23613.14%-2,317
ACELYRIN INC3,806,4103,806,410011,9529,4027.61%-2,550
ALUMIS INC2,787,3982,787,398021,90917,11513.85%-4,794
ALX ONCOLOGY HLDGS INC9,699,9259,699,925016,1996,0434.89%-10,156
ARTIVA BIOTHERAPEUTICS INC1,519,9711,198,975-320,99615,3213,5972.91%-11,724
PHARVARIS N V
COM
4,289,3044,289,304082,22667,34254.50%-14,884
Page 1 of 1